Related Experiment Video
Updated: May 7, 2026

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
The relationship between body growth and pulmonary function in children with cystic fibrosis
Janna W Woestenenk1, Rebecca K Stellato, Suzanne W Terheggen-Lagro
1Internal Medicine and Dermatology, Dietetics and, Cystic Fibrosis Centre Utrecht, University Medical Centre Utrecht, Utrecht, The Netherlands.
Insights
Children with cystic fibrosis (CF) experience impaired growth. However, weight gain in these patients significantly slowed the decline in lung function, specifically forced expiratory volume in 1 sec (FEV1).
Area of Science:
- Pediatric Pulmonology
- Growth and Development in Chronic Illness
- Cystic Fibrosis Research
Background:
- Children with cystic fibrosis (CF) often exhibit impaired growth patterns.
- Monitoring anthropometric measurements is crucial for assessing the health status of pediatric CF patients.
Purpose of the Study:
- To measure weight and height in children with CF aged 2-10 years.
- To investigate the relationship between anthropometric parameters and lung function (FEV1) from age 6.
Main Methods:
- Weight and height were assessed using z-scores: weight-for-age (WFA), height-for-age (HFA), height-adjusted-for-target-height (HFA/TH), and weight-for-height (WFH).
- Children were categorized based on z-scores at 2 years of age.
- Cross-sectional and longitudinal analyses examined the association between anthropometric measures and FEV1.
Main Results:
- Mean weight and height in the 156 enrolled CF children were below healthy population averages.
- While weight-for-age and weight-for-height improved with age, height deficits persisted.
- Weight gain was significantly associated with a slower yearly decline in FEV1 (1.8-1.9% decrease per unit increase in WFA/WFH).
Conclusions:
- Pediatric CF patients aged 2-10 years demonstrate persistent growth impairment.
- Interventions promoting weight gain can positively impact lung function trajectory in children with CF.
Aim:
To measure the weight and height of children with cystic fibrosis (CF) from 2 to 10 years of age and to investigate the relationship between these parameters and forced expiratory volume in 1 sec (FEV1) beginning at 6 years of age.
Methods:
Weight and height were expressed as z-scores for weight-for-age (WFA), height-for-age (HFA), height-adjusted-for-target-height (HFA/TH) and weight-for-height (WFH). The children were categorised as having a z-score ≥0, between 0 and -1, or <-1 based on z-scores at 2 years of age. The cross-sectional and longitudinal relationships between FEV1 and WFA, HFA, HFA/TH and WFH were determined and the predictive value of these parameters for FEV1.
Results:
We enrolled 156 CF children. Their mean weight and height were below the average for the healthy population. Both WFA and WFH increased with age (primarily before the age of 6), while the reduction in HFA and HFA/TH persisted. Importantly, the yearly decline in FEV1 was significantly slowed [by 1.8 and 1.9% for each unit increase in WFA and WFH (p < 0.015)] in children who gained weight.
Conclusion:
CF patients aged 2 to 10 years have long-term impaired growth. Nevertheless, weight gain slowed the decline in FEV1 in these patients.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
06:57The WinCF Model - An Inexpensive and Tractable Microcosm of a Mucus Plugged Bronchiole to Study the Microbiology of Lung Infections
Published on: May 8, 2017
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
Pulmonary Function Tests
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Pressure Relationships in Thoracic Cavity
Breathing Mechanisms
Both intra-alveolar and intrapleural pressures rely on specific lung properties. The ability to breathe—allowing air to enter the lungs...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History